Retraction of: HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells by Chi et al. (doi: 10.1089/hum.2017.256)

. 2022 May;33(9-10):572.

doi: 10.1089/hum.2017.256.retract. Epub 2022 Mar 28.

No authors listed

No authors listed. Hum Gene Ther. 2022 May.

. 2022 May;33(9-10):572.

doi: 10.1089/hum.2017.256.retract. Epub 2022 Mar 28.

No abstract available

Retraction of

HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells.
Chi C, Mao M, Shen Z, Chen Y, Chen J, Hou W. Chi C, et al. Hum Gene Ther. 2018 Dec;29(12):1438-1448. doi: 10.1089/hum.2017.256. Epub 2018 Sep 5. Hum Gene Ther. 2018. Retraction in: Hum Gene Ther. 2022 May;33(9-10):572. doi: 10.1089/hum.2017.256.retract. PMID: 29896986 Free PMC article. Retracted.

Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H, Ma Y, Zhong D, Yang L. Zhou H, et al. Biomed Pharmacother. 2019 Apr;112:108633. doi: 10.1016/j.biopha.2019.108633. Epub 2019 Feb 20. Biomed Pharmacother. 2019. PMID: 30784927
HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S, Li K. Chen S, et al. BMC Cancer. 2020 Sep 25;20(1):924. doi: 10.1186/s12885-020-07441-9. BMC Cancer. 2020. PMID: 32977766 Free PMC article.
HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.
Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X. Wang Q, et al. Onco Targets Ther. 2017 Sep 28;10:4753-4763. doi: 10.2147/OTT.S143787. eCollection 2017. Onco Targets Ther. 2017. PMID: 29033588 Free PMC article.
HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans.
Xie SC, Yang YJ, Zhang JQ, Zhou S, Xie SW, Hua YY. Xie SC, et al. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2898-2907. doi: 10.26355/eurrev_201904_17568. Eur Rev Med Pharmacol Sci. 2019. PMID: 31002165 Review.
Long non-coding RNA HOXD-AS1 in cancer.
Li L, Wang Y, Zhang X, Huang Q, Diao Y, Yin H, Liu H. Li L, et al. Clin Chim Acta. 2018 Dec;487:197-201. doi: 10.1016/j.cca.2018.10.002. Epub 2018 Oct 2. Clin Chim Acta. 2018. PMID: 30290157 Review.